Especially, serum CXCL9 may be a novel independent biomarker because it does not correlate with clinical ILD biomarkers, surfactant protein (SP)-A, SP-D, or KL-6 (S4 Table) [26]. This evidence concerns the gene CXCL9 and interstitial lung disease.